Screening for cervical cancer based on testing for human papillomavirus (HPV) increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia, but whether this ...
May 2, 2011 — Women treated for high-grade cervical lesions who subsequently have 3 consecutive negative cytologic smears face a 5-year risk of developing cervical cancer or recurrent disease similar ...
Human papillomavirus types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cervical cancers worldwide. A phase 3 trial was conducted to evaluate a quadrivalent vaccine against HPV types 6, 11, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results